Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Current Pathogenic Paradigm and Therapeutic Aspect
Changes in the gut microbiota are essential factors that cause non-alcoholic fatty liver disease (NAFLD), obesity, and diabetes. Small intestine bacteria overgrowth is discovered in NAFLD patients. Disruptions in the gut-liver axis include environmental factors that induce microbiota dysbiosis and/o...
Saved in:
| Main Authors: | Ummi Maimunah, Soebagijo Adi Soelistijo, Wiharjo Hadisuwarno, Muhammad Miftahussurur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2023-11-01
|
| Series: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
| Subjects: | |
| Online Access: | https://ina-jghe.com/index.php/jghe/article/view/874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-alcoholic fatty liver disease enhances the beneficial effect of renal denervation on gut microbiota aberrations in rats with heart failure
by: Fuyan Chen, et al.
Published: (2025-05-01) -
Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
by: Yutian Zhang, et al.
Published: (2025-06-01) -
Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01) -
The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017–2020
by: Ce Zheng, et al.
Published: (2025-03-01) -
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development
by: Zhou Z, et al.
Published: (2025-08-01)